Skip to main content

Table 5 Perceived adequacy of access to MOT by cancer patients

From: Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing

 

Physicians No. (%)

Testing labs No. (%)

Referring labs No. (%)

p-value

 

Mildly agree

Strongly agree

Mildly agree

Strongly agree

Mildly agree

Strongly agree

Mildly or strongly agree

Cancer patients are receiving the MOT that is indicated as a standard of care ...

...in my region

76/258 (29.5)

41/258 (15.9)

6/17 (35.3)

4/17 (23.5)

10/36 (27.8)

9/36 (25.0)

0.423

...in Ontario

58/253 (22.9)

21/253 (8.3)

3/17 (17.6)

4/17 (23.5)

10/37 (27.0)

4/37 (10.8)

0.535

Ontario compares favorably in ensuring access to MOT that is indicated as a standard of care with...

... other jurisdictions in Canada

49/254 (19.3)

28/254 (11.0)

5/14 (35.7)

2/14 (24.3)

8/36 (22.2)

4/36 (11.1)

0.296

... other jurisdictions in the US

25/253 (9.9)

11/253 (4.3)

0/15 (0)

1/15 (6.7)

2/34 (5.9)

2/34 (5.9)

0.878*

  1. *Fisher exact test